NCT01823172View on ClinicalTrials.gov

Second Echelon Node Study With Methylene Blue

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Breast CancerMelanoma
Interventions
PROCEDURE

Methylene blue dye injection of sentinel lymph node

Single arm study. Methylene blue will be injected into the 1st SLN and traced via the efferent lymphatic to the 2nd echelon lymph node.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER